“There's nothing here”: Deindustrialization as risk environment for overdose K McLean International Journal of Drug Policy 29, 19-26, 2016 | 165 | 2016 |
The biopolitics of needle exchange in the United States K McLean Critical Public Health 21 (1), 71-79, 2011 | 79 | 2011 |
“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine use in a time of treatment expansion K McLean, PR Kavanaugh International Journal of Drug Policy 71, 118-124, 2019 | 59 | 2019 |
Needle exchange and the geography of survival in the South Bronx K McLean International Journal of Drug Policy 23 (4), 295-302, 2012 | 46 | 2012 |
From “junkies” to “soccer moms”: Newspaper representations of overdose, 1988–2014 K McLean Critical Criminology 25 (3), 411-432, 2017 | 43 | 2017 |
“You never know what you’re getting”: opioid users’ perceptions of fentanyl in southwest Pennsylvania K McLean, SM Monnat, K Rigg, GE Sterner III, A Verdery Substance use & misuse 54 (6), 955-966, 2019 | 35 | 2019 |
Estimating the size of the methamphetamine-using population in New York City using network sampling techniques K Dombrowski, B Khan, T Wendel, K McLean, E Misshula, R Curtis Advances in applied sociology 2 (4), 245, 2012 | 35 | 2012 |
Network firewall dynamics and the subsaturation stabilization of HIV B Khan, K Dombrowski, M Saad, K McLean, S Friedman Discrete dynamics in nature and society 2013 (1), 720818, 2013 | 34 | 2013 |
Exploring first responders' perceptions of medication for addiction treatment: Does stigma influence attitudes? NE Kruis, K McLean, P Perry Journal of Substance Abuse Treatment 131, 108485, 2021 | 31 | 2021 |
Good Samaritans vs. predatory peddlers: problematizing the war on overdose in the United States K McLean Journal of crime and justice 41 (1), 1-13, 2018 | 31 | 2018 |
A reexamination of connectivity trends via exponential random graph modeling in two IDU risk networks K Dombrowski, B Khan, K McLean, R Curtis, T Wendel, E Misshula, ... Substance use & misuse 48 (14), 1485-1497, 2013 | 31 | 2013 |
Opioid misuse initiation: implications for intervention KK Rigg, K McLean, SM Monnat, GE Sterner III, AM Verdery Journal of addictive diseases 37 (3-4), 111-122, 2018 | 29 | 2018 |
Risk and enabling environments in sport: Systematic doping as harm reduction A Henning, K McLean, J Andreasson, P Dimeo International Journal of Drug Policy 91, 102897, 2021 | 18 | 2021 |
Reducing risk, producing order: The surprisingly disciplinary world of needle exchange K McLean Contemporary drug problems 40 (3), 415-445, 2013 | 16 | 2013 |
First responders’ views of naloxone: Does stigma matter? NE Kruis, K McLean, P Perry, MK Nackley Substance Use & Misuse 57 (10), 1534-1544, 2022 | 13 | 2022 |
Treatment trajectories and barriers in opioid agonist therapy for people who inject drugs in rural Puerto Rico R Abadie, K McLean, P Habecker, K Dombrowski Journal of substance abuse treatment 127, 108347, 2021 | 11 | 2021 |
Visualizing age, period, and cohort patterns of substance use in the US opioid crisis AM Verdery, K England, A Chapman, L Luo, K McLean, S Monnat Socius 6, 2378023120906944, 2020 | 11 | 2020 |
Motivations for diverted buprenorphine use in a multisite qualitative study PR Kavanaugh, K McLean Journal of Drug Issues 50 (4), 550-565, 2020 | 10 | 2020 |
A kind of peace: Tracking the reflexive and resilient drug war. K McLean The International Journal on Drug Policy 51, 117-120, 2017 | 8 | 2017 |
From responsible users to recalcitrant dope fiends: Mapping modes of engagement with harm reduction K McLean Addiction Research & Theory 23 (6), 490-498, 2015 | 8 | 2015 |